- Home
- WHD vs VCYT Comparison
WHD vs VCYT Comparison
Compare WHD & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WHD
- VCYT
- Stock Information
- Founded
- WHD 2011
- VCYT 2006
- Country
- WHD United States
- VCYT United States
- Employees
- WHD N/A
- VCYT N/A
- Industry
- WHD Metal Fabrications
- VCYT Medical Specialities
- Sector
- WHD Industrials
- VCYT Health Care
- Exchange
- WHD Nasdaq
- VCYT Nasdaq
- Market Cap
- WHD 2.9B
- VCYT 2.4B
- IPO Year
- WHD 2018
- VCYT 2013
- Fundamental
- Price
- WHD $40.65
- VCYT $31.34
- Analyst Decision
- WHD Buy
- VCYT Buy
- Analyst Count
- WHD 4
- VCYT 9
- Target Price
- WHD $50.75
- VCYT $39.89
- AVG Volume (30 Days)
- WHD 610.8K
- VCYT 992.1K
- Earning Date
- WHD 10-29-2025
- VCYT 11-05-2025
- Dividend Yield
- WHD 1.25%
- VCYT N/A
- EPS Growth
- WHD N/A
- VCYT N/A
- EPS
- WHD 2.67
- VCYT 0.34
- Revenue
- WHD $1,119,196,000.00
- VCYT $479,129,000.00
- Revenue This Year
- WHD N/A
- VCYT $14.19
- Revenue Next Year
- WHD $25.77
- VCYT $9.68
- P/E Ratio
- WHD $15.63
- VCYT $94.43
- Revenue Growth
- WHD N/A
- VCYT 19.91
- 52 Week Low
- WHD $33.80
- VCYT $22.61
- 52 Week High
- WHD $70.01
- VCYT $47.32
- Technical
- Relative Strength Index (RSI)
- WHD 46.48
- VCYT 57.37
- Support Level
- WHD $40.41
- VCYT $30.67
- Resistance Level
- WHD $43.70
- VCYT $32.34
- Average True Range (ATR)
- WHD 1.40
- VCYT 1.16
- MACD
- WHD 0.08
- VCYT -0.03
- Stochastic Oscillator
- WHD 22.66
- VCYT 64.94
About WHD Cactus Inc.
Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.